Resolvin E1-Chemerin receptor 1 axis is dysregulated in critical COVID-19 patients.

Silva-Pereira C, Reina-Couto M, Pereira-Terra P, Teixeira-Santos L, Martins S, Pinho D, Soares ML, Dias CC, Sarmento A, Tavares M, Guimarães JT, Paiva JA, Fraga S, Albino-Teixeira A, Roncon-Albuquerque R, Sousa T

Open source

DOI: 10.1016/j.intimp.2025.115669
Published: 2025 Dec 10
Container: International immunopharmacology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.intimp.2025.115669,
  title = {Resolvin E1-Chemerin receptor 1 axis is dysregulated in critical COVID-19 patients.},
  author = {Silva-Pereira C and Reina-Couto M and Pereira-Terra P and Teixeira-Santos L and Martins S and Pinho D and Soares ML and Dias CC and Sarmento A and Tavares M and Guimarães JT and Paiva JA and Fraga S and Albino-Teixeira A and Roncon-Albuquerque R and Sousa T},
  year = {2025},
  journal = {International immunopharmacology},
  doi = {10.1016/j.intimp.2025.115669},
  url = {https://doi.org/10.1016/j.intimp.2025.115669}
}

RIS

TY  - JOUR
TI  - Resolvin E1-Chemerin receptor 1 axis is dysregulated in critical COVID-19 patients.
AU  - Silva-Pereira C
AU  - Reina-Couto M
AU  - Pereira-Terra P
AU  - Teixeira-Santos L
AU  - Martins S
AU  - Pinho D
AU  - Soares ML
AU  - Dias CC
AU  - Sarmento A
AU  - Tavares M
AU  - Guimarães JT
AU  - Paiva JA
AU  - Fraga S
AU  - Albino-Teixeira A
AU  - Roncon-Albuquerque R
AU  - Sousa T
PY  - 2025
JO  - International immunopharmacology
DO  - 10.1016/j.intimp.2025.115669
UR  - https://doi.org/10.1016/j.intimp.2025.115669
ER  -

APA

C, S., M, R., P, P., L, T., S, M., D, P., ML, S., CC, D., A, S., M, T., JT, G., JA, P., S, F., A, A., R, R., & T, S. (2025). Resolvin E1-Chemerin receptor 1 axis is dysregulated in critical COVID-19 patients.. International immunopharmacology. https://doi.org/10.1016/j.intimp.2025.115669

Source records

pubmed · retrieved 2026-09-27T14:01:40.995Z